Janel Reynolds, NP
Primary Care · Midlothian, VANPI 1295370252
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations.
Across 182 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$462
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$446
- Averitas Pharma Inc.$243
- Pfizer$217
- AbbVie$214
- Boston Scientific$176
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,230100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 23 | $462 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 35 | $446 |
| Averitas Pharma Inc. | 20 | $243 |
| Pfizer | 10 | $217 |
| AbbVie | 11 | $214 |
| Boston Scientific | 9 | $176 |
| Medtronic | 3 | $156 |
| GRT US Holding, Inc. | 13 | $156 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $151 |
| Globus Medical | 3 | $136 |
| Lilly USA, LLC | 6 | $120 |
| Vertex | 6 | $117 |
| Biodelivery Sciences International, Inc. | 9 | $114 |
| Mallinckrodt Hospital Products Inc. | 3 | $101 |
| Si-bone, Inc. | 3 | $97 |
| Arbor Pharmaceuticals, Inc. | 5 | $89 |
| ERMI LLC | 1 | $45 |
| Pacira Pharmaceuticals Incorporated | 2 | $42 |
| Scilex Pharmaceuticals Inc. | 2 | $29 |
| Upsher-smith Laboratories LLC | 2 | $26 |
| Tonix Medicines, Inc. | 1 | $24 |
| Avanos Medical | 1 | $24 |
| IBSA Pharma Inc. | 1 | $18 |
| Bioventus LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$125
How this compares
$3,230 in reported general payments places this provider in the 85th percentile of 142 primary care providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,082 | $29,848 |
| RelistorMethylnaltrexone Bromide | 14 | $28,881 |
| HorizantGabapentin Enacarbil | 11 | $21,761 |
| Xtampza ErOxycodone Myristate | 41 | $19,379 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 716 | $15,604 |
| Diclofenac Sodium | 188 | $15,061 |
| Gabapentin | 643 | $9,441 |
| Oxycodone Hcl | 447 | $9,436 |
| OxycontinOxycodone Hcl | 31 | $9,340 |
| Pregabalin | 219 | $7,481 |
| Lidocaine | 52 | $5,632 |
| Morphine Sulfate ErMorphine Sulfate | 94 | $3,035 |
| Tramadol Hcl | 392 | $2,800 |
| Tramadol Hcl ErTramadol Hcl | 23 | $1,695 |
| Cyclobenzaprine Hcl | 184 | $1,620 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $446 | $28,88114 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $89 | $21,76111 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $462 | $19,37941 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 142 primary care providers in Virginia.
Other primary care in Midlothian
- Lauren ToddMidlothian$4K
- Julia RobinettMidlothian$765
- Rebecca GrinsellRichmond$12K
- Jennifer CampbellNewport News$8K
- Tien MaAnnandale$7K
- Michael CogginAshland$7K
- Erin StewartFredericksburg$6K
- Lawanda WoodNorfolk$6K
- Sara WeaverDanville$5K
- Luis Rivera PenaFalls Church$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.